MG
Metagenomi, Inc. Common Stock
MGX · NASDAQ
$1.14 +6.54% (+$0.07)
1M -7.44%
Market Cap $42.5M
P/E Ratio -
Div. Yield -
ROE 63.65%
Piotroski F-Score Weak
2/9Valuation
78 /100
Cheap P/B 0.38x
P/S 3.14x
P/FFO N/A
Growth
82 /100
Growing Rev. growth 13.59%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 741.58%
Gross margin 74.29%
FCF margin 632.67%
Quality
1 /100
Poor ROA 53.81%
ROIC 65.88%
Asset turnover 0.08x
Debt
98 /100
Low Current ratio 4.50x
Debt/Equity 0.34x
Debt/Assets N/A
Stability
48 /100
Moderate EPS volatility 24.86%
Beta 0.68x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o MGX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Irish
Employees
113
Headquarters
Emeryville
Nadchodzące wydarzenia
10 LIS
Earnings
Upcoming earnings report